Quarterly Ending March 31, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 2/2018 dated May 10, 2018
advisor and extraordinary general meeting of shareholders. Management benefit expenses In Q1/2018, the management benefit was Baht 4.35 million compare with the same period of previous year amount to Baht
of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2019, held on 20th February 2019, approved the audited financial statements, including the consolidated
and Analysis for Year Ending December 31, 2018 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 1/2019
Exchange of Thailand The Board of Directors meeting of KGI Securities (Thailand) Plc (“the Company”), No.1/2020, held on 19th February 2020, approved the audited financial statements, including the
Discussion and Analysis for Year Ending December 31, 2019 To : The President The Stock Exchange of Thailand The Board of Directors meeting of Ratchaphruek Hospital Public Company Limited (the Company) No. 1
the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company
Company Limited (JSP) held the Board of Directors’ meeting no. 8/2560 on July 3, 2017, approved the Company to receive financial assistance from connected persons is as follows :- 1. Date of entering into
the risk of incomes. 8. Opinion of the board of directors on entering into transaction: The board of directors’ meeting of the Company unanimously resolved to approve the entering into the transaction